ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

Do Minh Thai

Director, Statistics and Methodology

Do Minh Thai brings four decades of experience in biostatistics to his role as Director of Statistics and Methodology. Influential since the inception of ZEG Berlin, he has comprehensive knowledge in the analysis of clinical and epidemiological studies with particular expertise in the management of large databases.  He coordinates the complex statistical analysis on multiple ZEG Berlin projects.

Thai studied mathematics at the University of Greifswald (Germany), receiving his PhD in Mathematical Cybernetics and Computer Sciences in 1977.  Throughout his career Thai has established himself as a reputable partner delivering exacting study design, data management and data analysis.

 

Publications

Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Venous thromboemolism in users of a 24-day regimen of a combined oral contraceptive compare to conventional 21-day regimens: final results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.
Heinemann Lothar A , Do Minh Thai, Heinemann Klaas, Lindemann M , Filonenko A, Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women International. 2012; Feb;33(2):109-24.
Dinger Jürgen, Bardenheuer Kristina, Do Minh Thai, Dose of estrogen and contraceptive failure rates of combined oral contraceptives. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 75.
Dinger Jürgen, Do Minh Thai, Bardenheuer Kristina, Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstetrics and Gynecology. 2011; 117:33-40.
Dinger Jürgen, Do Minh Thai, Early use effects on the risk of venous thromboembolism after initiation of oral contraceptive use. Eur J Contracept Reprod Health Care. 2010; 15;S1:43.
Dinger Jürgen, Assmann Anita, Moehner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.
Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Franke Christian, Leddin Janko, Differences in drug utilization of oral contraceptives in the US and Europe. Pharmacoepidemiology and Drug Safety. 2010; 19:S241.
Heinemann Lothar A , Do Minh Thai, Filonenko A, Uhl-Hochgräber K, Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. The Patient. Patient-Centered Outcomes Research. 2010; 3(2):113-123.
Dinger Jürgen, Do Minh Thai, The risk of venous thromboembolism in OC users: time patterns after initiation of treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S214-215.
Dinger Jürgen, Cronin Maureen, Schellschmidt Ilka, Do Minh Thai, Westhoff C, Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009; Sep;201(3):263.e1-9. doi: 10.1016/j.ajog.2009.03.017.
Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.
Raff T, Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.
Schellschmidt I, Do Minh Thai, Dinger Jürgen, Factors influencing return to fertility after use of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S25.
Kratzik C, Heinemann Lothar A , Saad F, Do Minh Thai, Rücklinger E, Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male. 2005; 8 (3/4):157-161.
Heinemann Lothar A , Saad F, Heinemann Klaas, Do Minh Thai, Can results of the AMS scale predict those of screening scales for androgen deficiency?. Aging Male. 2004; 7:211-18.
Heinemann Klaas, Alexander Ruebig Alexander, Potthoff P, Schneider HPG, Strelow Frank, Heinemann Lothar A , Do Minh Thai, The Menopause Rating Scale: A methodological review. Health and Quality of Life Outcomes. 2004; 2:45 (2 September 2004). 10.1186/1477-7525-2-45.
Heinemann Klaas, Heinemann Lothar A , Do Minh Thai, Möhner M, Heuchert G E, Occupational exposure and liver cancer in women: results of the Multicentre International Liver Tumour Study (MILTS). Occup Med (Lond). 2000; Aug;50(6):422-9.
Heinemann Lothar A , Thorogood M, Kerle K M, Assmann Anita, Do Minh Thai, Use of psychotropic drugs and risk of cardiovascular events. Life and Medical Science Online. 2000; 1.